Literature DB >> 10673176

Differential metabolism of arachidonic acid in nasal polyp epithelial cells cultured from aspirin-sensitive and aspirin-tolerant patients.

M L Kowalski1, R Pawliczak, J Wozniak, K Siuda, M Poniatowska, J Iwaszkiewicz, T Kornatowski, M A Kaliner.   

Abstract

The mechanism of aspirin (acetylsalicylic acid [ASA]) sensitivity associated with severe asthma and chronic rhinosinusitis with nasal polyps ("aspirin triad") has been attributed to arachidonic metabolism alternations, although the putative biochemical defects have not been elucidated. The aim of this study was assessment of the hypothesis that local production of eicosanoids in the respiratory epithelium in patients with ASA-sensitive asthma/rhinosinusitis (ASARS) differs from that of ASA-tolerant patients with rhinosinusitis (ATRS). Nasal polyps were obtained from 10 patients with ASARS and 15 with ATRS during routine polypectomies, and epithelial cells (ECs) were cultured on bovine collagen type I matrix (Vitrogen 100), in medium supplemented with growth factors. The generation of eicosanoids in supernatants of confluent ECs (6 to 8 d of culture; purity > 98%) was quantified by immunoassays. Unstimulated ECs from ASARS patients generated significantly less prostaglandin E(2)(PGE(2)) compared with ATRS (0.8 +/- 0.3 versus 2. 4 +/- 0.5 ng/microg double-stranded deoxyribonucleic acid [dsDNA], respectively), although a similar relative increase in response to calcium ionophore and inhibition with ASA was observed in both groups. Basal levels of 15-hydroxyeicosatetraenoic acid (15-HETE) were not different between groups, and calcium ionophore enhanced its production to a similar extent. However, cells incubation with 200 microM ASA for 60 min resulted in a significant increase (mean +359%) in 15-HETE generation only in ASARS patients, whereas no effect of ASA on 15-HETE generation in ATRS patients was observed. PGF(2alpha) generation was similar in both groups, and no significant generation of PGD(2) or leukotriene C(4) (LTC(4)) was observed in epithelial cell cultures from either group. Our results indicate that nasal polyps ECs from ASA-sensitive patients have significant abnormality in basal and ASA-induced generation of eicosanoids which may be causally related to the mechanism of ASA sensitivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673176     DOI: 10.1164/ajrccm.161.2.9902034

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  41 in total

Review 1.  Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: are they different?

Authors:  M L Kowalski
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

Review 2.  Update on aspirin desensitization for chronic rhinosinusitis with polyps in aspirin-exacerbated respiratory disease (AERD).

Authors:  Ronald A Simon; Kristen M Dazy; Jeremy D Waldram
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

3.  Prostaglandin E2 deficiency uncovers a dominant role for thromboxane A2 in house dust mite-induced allergic pulmonary inflammation.

Authors:  Tao Liu; Tanya M Laidlaw; Chunli Feng; Wei Xing; Shiliang Shen; Ginger L Milne; Joshua A Boyce
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 4.  The role of local steroid injection for nasal polyposis.

Authors:  Marcelo B Antunes; Samuel S Becker
Journal:  Curr Allergy Asthma Rep       Date:  2010-05       Impact factor: 4.806

5.  Sinonasal outcome under aspirin desensitization following functional endoscopic sinus surgery in patients with aspirin triad.

Authors:  Miriam Havel; Lena Ertl; Franziska Braunschweig; Sabine Markmann; Andreas Leunig; Fernando Gamarra; Matthias F Kramer
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-18       Impact factor: 2.503

6.  Prostaglandin E(2) exerts homeostatic regulation of pulmonary vascular remodeling in allergic airway inflammation.

Authors:  Anders Lundequist; Samridhi N Nallamshetty; Wei Xing; Chunli Feng; Tanya M Laidlaw; Satoshi Uematsu; Shizuo Akira; Joshua A Boyce
Journal:  J Immunol       Date:  2010-01-01       Impact factor: 5.422

Review 7.  Aspirin intolerance and nasal polyposis.

Authors:  César Picado
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

Review 8.  Aspirin-induced asthma: clinical aspects, pathogenesis and management.

Authors:  Ahmed M Hamad; Amy M Sutcliffe; Alan J Knox
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Aspirin-exacerbated asthma.

Authors:  Mathew Varghese; Richard F Lockey
Journal:  Allergy Asthma Clin Immunol       Date:  2008-06-15       Impact factor: 3.406

Review 10.  Update on recent advances in the management of aspirin exacerbated respiratory disease.

Authors:  Nami Shrestha Palikhe; Joo-Hee Kim; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.